<DOC>
	<DOCNO>NCT02075554</DOCNO>
	<brief_summary>The primary objective study evaluate safety efficacy CALIBER expandable spacer treatment degenerative disc disease . Radiographic outcomes , intra-operative parameter , clinical outcome , patient satisfaction obtain patient 2 year follow-up clinical study .</brief_summary>
	<brief_title>Efficacy Safety Expandable Spacer Treatment Degenerative Disc Disease Using Minimally Invasive Transforaminal Lumbar Interbody Fusion Surgical Approach</brief_title>
	<detailed_description>Patients followed-up 3weeks , 6 week , 3 month , 6 month , 12 24 month X-rays questionnaire determine satisfaction , healing , fusion return work status</detailed_description>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>DDD 1 2 level L2 S1 Between 18 80 year age Unresponsiveness document nonsurgical treatment modality minimum six month Ability provide sign Informed Consent Trauma level ( ) fuse Previous documentation osteopenia , osteoporosis , osteomalacia degree spinal instrumentation would contraindicate Immunosuppressive disorder History substance abuse Any known allergy metal alloy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>